bixalomer and Coronary-Disease

bixalomer has been researched along with Coronary-Disease* in 1 studies

Reviews

1 review(s) available for bixalomer and Coronary-Disease

Article	Year
[Pharmacological and clinical profile of bixalomer (Kiklin(®) capsules): a new therapeutic agent for hyperphosphatemia]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2013, Volume: 141, Issue:6 Topics: Animals; Capsules; Chelating Agents; Clinical Trials, Phase III as Topic; Coronary Disease; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Phosphoric Acids; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk	2013

Article

Year

[Pharmacological and clinical profile of bixalomer (Kiklin(®) capsules): a new therapeutic agent for hyperphosphatemia].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2013, Volume: 141, Issue:6

Topics: Animals; Capsules; Chelating Agents; Clinical Trials, Phase III as Topic; Coronary Disease; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Phosphoric Acids; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk

2013